Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis [NA]
The study investigates whether torso weighting affects muscle activation during balance tests in people with multiple sclerosis and in those…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI
This clinical trial update reports on a study assessing early identification of brain lesions in multiple sclerosis using Phase Sensitive In…
-
FDA approval · 2025-05-16FDA Approved: GLATIRAMER ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for glatiramer acetate from Sun Pharmaceutical Industries, expanding the approval of a generic p…
-
FDA approval · 2025-05-16FDA Approved: GLATIRAMER ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for glatiramer acetate submitted by Sun Pharmaceutical Industries, Inc. This action approves cha…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China [Phase 4]
Phase 4 study of dimethyl fumarate for relapsing forms of multiple sclerosis in Chinese participants has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Mixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS) [NA]
A clinical trial update for the VIRTUALDOMUS mixed-reality upper limb rehabilitation program in people with Multiple Sclerosis, sponsored by…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis
An ongoing IOBA-sponsored study is evaluating visual processing speed and objective ocular movement analysis in individuals with Multiple Sc…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Territorial Implementation and Evaluation of a Multiple Sclerosis Expert Patient Program [NA]
This completed clinical trial evaluated the territorial implementation and evaluation of a Multiple Sclerosis Expert Patient Program, focusi…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Internet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments [NA]
This clinical trial update notes that an internet-delivered cognitive rehabilitation program is enrolling by invitation for individuals with…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Evaluation of the Microbiome in Multiple Sclerosis [NA]
A clinical trial evaluating the microbiome in individuals with multiple sclerosis has been terminated. The status of the study is TERMINATED…
-
EMA approval · 2025-05-15EMA Authorised: Dimethyl fumarate Mylan (dimethyl fumarate) — Mylan Ireland Limited
EMA authorised Dimethyl fumarate Mylan for the treatment of multiple sclerosis. The marketing authorization holder is Mylan Ireland Limited.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Swiss Multiple Sclerosis Registry
The Swiss Multiple Sclerosis Registry trial (NCT02980640) is currently recruiting participants with multiple sclerosis.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Serum Auto-Antibodies in Neurological Diseases
Clinical trial update describing an ongoing study on serum auto-antibodies in neurological diseases, with enrollment by invitation and inclu…
-
CLINICAL_TRIALS safety_alert · 2025-05-13Clinical Trial Update: TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants
This document summarizes the TOPIK study update, a completed trial assessing cases of progressive multifocal leukoencephalopathy and other s…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Exercise Therapy in Multiple Sclerosis [NA]
A completed clinical trial evaluating exercise therapy for individuals with multiple sclerosis. The study status is completed.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Effectiveness of Personalized Alternating Current Stimulation for Treating Cognitive Impairment in CNS Demyelination Patients [NA]
A clinical trial is evaluating personalized alternating current stimulation to treat cognitive impairment in CNS demyelination, focusing on …
-
CLINICAL_TRIALS research · 2025-05-12Clinical Trial Update: COVID-19 Vaccine Biomarker Study in Multiple Sclerosis
This clinical trial update confirms the completion of a biomarker study evaluating a COVID-19 vaccine in individuals with Multiple Sclerosis…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study
FutureMS-2 is an observational cohort and precision medicine study in Scotland focusing on multiple sclerosis, currently enrolling by invita…
-
CLINICAL_TRIALS other · 2025-05-11Clinical Trial Update: Optimising Access to Vocational Rehabilitation for People With Multiple Sclerosis [NA]
This clinical trial update describes a study aimed at optimizing access to vocational rehabilitation for people with Multiple Sclerosis and …
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis [NA]
A clinical trial from Universita di Verona is evaluating cognitive rehabilitation delivered via telerehabilitation for people with multiple …
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Examining the Effect of Mandala Art Therapy on Symptoms and Quality of Life in Multiple Sclerosis Patients [NA]
A clinical trial is evaluating mandala art therapy for symptoms and quality of life in people with multiple sclerosis. The study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Epstein Barr Virus Infection in Patients With Radiologically Isolated Syndrome
A completed clinical trial update investigates Epstein-Barr virus infection in patients with radiologically isolated syndrome, exploring its…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis [Phase 2]
A randomized, double-blind Phase 2 trial evaluated the efficacy and safety of autologous HB-MSCs versus placebo in multiple sclerosis; resul…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS [NA]
An active clinical trial sponsored by the Kessler Foundation is evaluating a theory-driven manualized approach to improving new learning and…
-
FDA approval · 2025-05-07FDA Approved: GLATIRAMER ACETATE — Original Application (Italfarmaco SpA)
The FDA approved Italfarmaco SpA's generic Glatiramer acetate via an Original Application (ANDA 208468). The product is for the treatment of…